The Therapeutic Effect of Thalidomide in Syringomyelia

Clinical trial NCT06268093 · RECRUITING

Trial details

NCT number: NCT06268093
Sponsor: Xuanwu Hospital, Beijing
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Syringomyelia Thalidomide

Start date: 2024-02-01
Primary completion: 2027-02-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.